SGLT2 inhibitors can reduce the incidence of abnormal blood glucose caused by statins in non-diabetes patients with HFrEF after PCI
Article in BMC Cardiovascular Disorders (June 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in BMC Cardiovascular Disorders (June 2023)
Article in Chinese Journal of Geriatrics (November 2019)
Article in Hormones (September 2018)